Babich John W 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009
Insider Transaction Report
Form 4
Babich John W
DirectorPresident, CEO and CSO
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+200,000→ 200,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in two equal annual installments of 100,000 shares each on May 12, 2010 and May 12, 2011, respectively.